Hsinchu, Taiwan

Tzuyin Lin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Agricultural Technology Research Institute. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tzuyin Lin: Innovator in Cell Transduction Efficiency

Introduction

Tzuyin Lin is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of biotechnology, particularly in enhancing cell transduction efficiency. His innovative work has the potential to impact therapeutic applications significantly.

Latest Patents

Tzuyin Lin holds a patent for a recombinant polypeptide designed to enhance the cell transduction efficiency of a target agent. The invention involves a recombinant polypeptide X-Y, where X is a cell-penetrating peptide known as DPV3, and Y is an Hsp40-J domain. This invention also includes a method for improving cell transduction efficiency by conjugating the target agent with the recombinant polypeptide. Additionally, it provides a pharmaceutical composition that modifies a therapeutic agent through this conjugation.

Career Highlights

Tzuyin Lin is associated with the Agricultural Technology Research Institute, where he continues to explore advancements in biotechnology. His work focuses on developing innovative solutions that can enhance the effectiveness of therapeutic agents.

Collaborations

Some of Tzuyin Lin's coworkers include Chin-Kai Chuang and Yu-Hsiu Su, who contribute to the collaborative efforts in research and development within their institution.

Conclusion

Tzuyin Lin's contributions to biotechnology, particularly in cell transduction efficiency, highlight his role as an innovator in the field. His patent and ongoing research have the potential to lead to significant advancements in therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…